Results 81 to 90 of about 22,865 (194)

Advances and Prospects of Stereotactic Radiosurgery and Stereotactic Ablative Body Radiotherapy: Evolving Paradigms in Precision Oncology

Med Research, Volume 2, Issue 1, Page 157-180, March 2026.
The graphical abstract outlines the progressive development and impact of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Technological Evolution illustrates the transition from brachytherapy with single‐dose, LDR/HDR schedules to fractionated radiotherapy, three‐dimensional conformal radiotherapy (3DCRT) and Gamma Knife ...
Jing Zhang, Wenhao Xu, Weiqing Lu, Yingxuan Lin, Luoxi He, Zonglin Lv, Yiliyaer Nuerrula, Zouting, Zhen Zhang, Hailiang Zhang, Xuejun Ma   +10 more
wiley   +1 more source

The Eye Never Lies: When A Lesion Unveils Lung Cancer

Respirology Case Reports, Volume 14, Issue 3, March 2026.
We present a rare case of asymptomatic primary lung adenocarcinoma that first manifested with ocular symptoms and an iris lesion. ABSTRACT Ocular manifestations rarely represent the first sign of systemic malignancy and often pose a diagnostic challenge. While choroidal metastases are more common, iris involvement is uncommon and may be underrecognized.
Sivanesan Darshini, Nor Safiqah Sharil, Boon Hau Ng, Xin Yee Chong, Andrea Yu‐Lin Ban, Nik Nuratiqah Nik Abeed   +5 more
wiley   +1 more source

Long‐Term Outcomes and Natural Course of Giant Cerebral Arteriovenous Malformations (> 6 cm): Insights From a National Multicenter Propensity Score‐Matched Cohort

European Journal of Neurology, Volume 33, Issue 3, March 2026.
This multicenter prospective study of 380 patients with giant cerebral arteriovenous malformations (> 6 cm) found an overall annual rupture rate of 3.6%. Interventional treatment did not decrease long‐term hemorrhagic stroke or death compared with conservative management and carried higher risks of hemorrhage and neurological deterioration.
Nan Li, Yukun Zhang, Chengzhuo Wang, Heze Han, Li Ma, Ruinan Li, Zhipeng Li, Haibin Zhang, Kexin Yuan, Anqi Li, Qinghui Zhu, Yongenbo Su, Dezhi Gao, Hengwei Jin, Youxiang Li, Shibin Sun, Yuanli Zhao, Shuo Wang, Yu Chen, Hao Wang, Xiaolin Chen, Jizong Zhao, on behalf of Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China (MATCH)   +22 more
wiley   +1 more source

Reply: “Leigh Syndrome Due to the Variant c.1019T>C in COX15”

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 847-848, March 2026.
Haya S. AlFaris, Sangeetha Yoganathan, Marcus N. Callister, Liali Aljouda, Vivek Pai, Pradeep Krishnan, Andrea LeBlanc Miller, Christos Ganos, Carolina Gorodetsky   +8 more
wiley   +1 more source

Brain Dose–Volume Thresholds and Survival in Dogs With Intracranial Tumours Treated With the 10 × 4 Gy Radiotherapy Schedule: A Combined Analysis of Two Trials

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 177-185, March 2026.
ABSTRACT Dogs with intracranial tumours routinely receive radiotherapy, yet species‐specific dose–volume constraints for normal brain tissue remain undefined. In human radiation oncology, exceeding certain brain dose–volume thresholds markedly increases the risk of radiation‐induced injury (e.g., radionecrosis).
Sergejs Unterkirhers, Valeria Sabina Meier, Carla Rohrer Bley   +2 more
wiley   +1 more source

The efficacy of surgery over stereotactic radiosurgery in the management of tumor-related trigeminal neuralgia

Chinese Neurosurgical Journal
Tumor-related trigeminal neuralgia (TN) is a deeply debilitating condition that severely impacts patient quality of life. Two principal treatment methods in use are open surgical resection of the causative tumor or the use of stereotactic radiosurgery ...
Alexander Abouharb, Hasithe Rathnayake, Sachit Mehta   +2 more
doaj   +1 more source

The Application of PD‐1 Inhibitors in Immunotherapy for Glioblastoma

The FASEB Journal, Volume 40, Issue 4, 28 February 2026.
The molecular mechanism of PD‐1. When PD‐1 binds to PD‐L1, the ITIM and ITSM domains within PD‐1 are phosphorylated and subsequently recruit SHP‐2. This then dephosphorylates downstream molecules of the TCR, such as PI3K/AKT and ZAP70, reduces the secretion of IFN‐γ, and inhibits the presentation of antigens to T cells via MHC molecules through the ...
Ming‐zhen Dong, Ming Cui, Lin‐zhuo Qu, Hui‐ying Che, Hong‐jian Guan   +4 more
wiley   +1 more source

Stereotactic fractionated radiotherapy for multiple brain metastasis treated with single isocenter multitargeted approach: a case report

Journal of Current Oncology and Medical Sciences
Introduction: Adult patients with solid cancers frequently develop brain metastases. Whole brain radiotherapy (WBRT) alone or Stereotactic radiosurgery/radiotherapy (SRS/SRT) alone or in combination can be considered in Brain metastasis.
Siddharth Arora , Kriti Grover
doaj  

“Beyond the Knife”—Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology

Brain Sciences
The current standard of care for brain tumor management includes maximal safe surgical resection followed by concurrent chemotherapy and radiation therapy.
Santosh Guru, Fred C. Lam, Amirhossein Akhavan-Sigari, Yusuke S. Hori, Deyaaldeen AbuReesh, Armine Tayag, Sara C. Emrich, Louisa Ustrzynski, David J. Park, Steven D. Chang   +9 more
doaj   +1 more source

[Stereotactic radiosurgery].

Cirugia y cirujanos, 2005
Stereotactic radiosurgery (SRS) is a way of treating brain disorders with a precise delivery of a single high dose of radiation in a one-day session. Treatment involves the use of focused radiation beams delivered to a specific area of the brain to treat abnormalities, tumors or other functional disorders.
Ignacio, Madrazo-Navarro, Aurora, Aldana-Herrero   +1 more
openaire   +1 more source